Minodronic acid (also known as minodronate, brand names Bonoteo and Recalbon) is a potent, third-generation nitrogen-containing bisphosphonate drug used mainly for the treatment of osteoporosis. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Minodronate and Onobis. Its PubChem CID is 130956.
Minodronic acid
| CAS No | 180064-38-4 |
|---|---|
| Molecular Formula | C9H12N2O7P2 |
| Molecular Weight | 322.15 g/mol |
| Synonyms | (1-hydroxy-2-imidazo[1,2-a]pyridin-3-yl-1-phosphonoethyl)phosphonic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Minodronic acid (also known as minodronate, brand names Bonoteo and Recalbon) is a potent, third-generation nitrogen-containing bisphosphonate drug used mainly for the treatment of osteoporosis.
The listed CAS number is 180064-38-4.
The listed molecular formula is C9H12N2O7P2.
The listed molecular weight is 322.15 g/mol.
(1-hydroxy-2-imidazo[1,2-a]pyridin-3-yl-1-phosphonoethyl)phosphonic acid.
The source lists Minodronate and Onobis.